News
The FDA said it is making 'enhancements' designed to help states develop programs for importing cheaper drugs from Canada.
FTC sends new warning letters to Teva, Novartis, Amphastar, Viatris's Mylan, and Covis Pharma over allegedly improper drug ...
Eikon Therapeutics is laying off staff for the second time in 19 months, responding to 'changes in external circumstances' ...
The FDA's Oncologic Drugs Advisory Committee on Wednesday voted 5 to 4 against UroGen’s mitomycin as an option for low-grade ...
BioNTech to invest £1B in UK R&D over 10 years, receives £129M government grant to build research centers and HQ in London, ...
Weill Cornell Medicine study shows cocaine vaccine triggers antibodies & reduces drug use in small trial, but effects modest.
Moderna pulls BLA for its Covid-flu shot: The company suggested on its most recent … Get free access to a limited ...
Genentech signs $105M upfront deal with Orionis Biosciences to develop molecular glue cancer drugs, with potential milestones ...
Altos, led by industry stalwarts Hal Barron and Hans Bishop, brought Dorian Therapeutics into its fold this week, according ...
Juvenescence is out with a $76 million Series B-1, its first equity funding since before the Covid-19 pandemic.
Duncan Reece shares why his dementia care startup Veronica Health closed before seeing patients, citing fundraising challenges and investor skepticism of value-based care.
Two weeks into his tenure leading the FDA’s biologics center, Vinay Prasad has made his mark with a new framework for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results